Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia
|
August 23, 2013
The osseointegration of zirconia dental implants
Patrick A Assal
Arquivos De Cirurgia Clinica E Experimental
|
February 19, 2014
[Varices of the lower extremities]
F A ASSAL
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
March 29, 2011
[Chagas disease and blood transfusion: an emerging issue in non-endemic countries]
A Assal, C Corbi
Canadian Journal of Gastroenterology & Hepatology
|
January 10, 2015
Esophageal stricture due to magnesium citrate powder ingestion: a unique case
A Assal, N Saloojee, H Dhaliwal
Brain Research
|
November 28, 1994
Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020
M F Jarvis, A A Assal, G Gessner
Brain Research. Brain Research Protocols
|
February 1, 1997
[125I]BQ3020, a novel endothelin agonist selective for the endothelinB receptor subtype
A A Assal, G Gessner, M F Jarvis
Bulletin De La Societe De Pathologie Exotique (1990)
|
February 5, 2010
[Chagas disease screening in the blood donor population]
A Assal, B Pelletier, B David, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 1, 1995
In vivo immunosuppressive effects of recombinant ovine interferon-tau (trophoblastin): r.oTP (r.oIFN-tau) inhibits local GVH reaction in mice (PLN assay), prevents fetal resorptions, and favors embryo survival and implantation in the CBA/J x DBA/2 mice combination
A Assal-Meliani, R Kinsky, J Martal, et al.
Journal of Reproductive Immunology
|
November 1, 1993
Recombinant ovine trophoblastin (roTP) inhibits ovine, murine and human lymphocyte proliferation
A Assal-Meliani, G Charpigny, P Reinaud, et al.
Frontiers in Medicine
|
February 25, 2026
Editorial: Regulators of the immune-tumor microenvironment: a new frontier for cancer immunotherapy
Reem A Assal, Rana A Youness, Mai F Ragab, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia
|
August 23, 2013
The osseointegration of zirconia dental implants
Patrick A Assal
Arquivos De Cirurgia Clinica E Experimental
|
February 19, 2014
[Varices of the lower extremities]
F A ASSAL
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
March 29, 2011
[Chagas disease and blood transfusion: an emerging issue in non-endemic countries]
A Assal, C Corbi
Canadian Journal of Gastroenterology & Hepatology
|
January 10, 2015
Esophageal stricture due to magnesium citrate powder ingestion: a unique case
A Assal, N Saloojee, H Dhaliwal
Brain Research
|
November 28, 1994
Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020
M F Jarvis, A A Assal, G Gessner
Brain Research. Brain Research Protocols
|
February 1, 1997
[125I]BQ3020, a novel endothelin agonist selective for the endothelinB receptor subtype
A A Assal, G Gessner, M F Jarvis
Bulletin De La Societe De Pathologie Exotique (1990)
|
February 5, 2010
[Chagas disease screening in the blood donor population]
A Assal, B Pelletier, B David, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 1, 1995
In vivo immunosuppressive effects of recombinant ovine interferon-tau (trophoblastin): r.oTP (r.oIFN-tau) inhibits local GVH reaction in mice (PLN assay), prevents fetal resorptions, and favors embryo survival and implantation in the CBA/J x DBA/2 mice combination
A Assal-Meliani, R Kinsky, J Martal, et al.
Journal of Reproductive Immunology
|
November 1, 1993
Recombinant ovine trophoblastin (roTP) inhibits ovine, murine and human lymphocyte proliferation
A Assal-Meliani, G Charpigny, P Reinaud, et al.
Frontiers in Medicine
|
February 25, 2026
Editorial: Regulators of the immune-tumor microenvironment: a new frontier for cancer immunotherapy
Reem A Assal, Rana A Youness, Mai F Ragab, et al.
Page
of 4